Toggle navigation
Browse
Home
People
Departments & Colleges
Research
Research Area Overlaps
Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2)
Article (Web of Science)
Overview
Research
Additional Document Info
View All
Overview
cited authors
Spigel, David; Jotte, Robert; Nemunaitis, John; Shum, Merrill; Schneider, Jeffrey; Goldschmidt, Jerome; Eisenstein, Jennifer; Berz, David; Seneviratne, Lasika; Socoteanu, Matei; Bhanderi, Viralkumar; Konduri, Kartik; Xia, Meng; Wang, Hong; Hozak, Rebecca R.; Gueorguieva, Ivelina; Ferry, David; Gandhi, Leena; Chao, Bo H.; Rybkin, Igor
publication date
February 1, 2021
webpage
Web of Science
published in
JOURNAL OF THORACIC ONCOLOGY
Journal
Research
category
RESPIRATORY SYSTEM
Category
keywords
Interleukin (IL)-10
Nivolumab
Non-small cell lung cancer
Pegilodecakin
Pembrolizumab
Additional Document Info
start page
327
end page
333
volume
16
issue
2